Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Christiane Ferran, PH.D., M.D.

TitleProfessor of Surgery
InstitutionBeth Israel Deaconess Medical Center
DepartmentSurgery
AddressBeth Israel Deaconess Medical Center
Ctr for Vascular Biology Research, RN 370 F/G
99 Brookline Ave
Boston MA 02215
Phone617/632-0840
Fax617/667-0445
Other Positions
TitleAssociate Professor of Medicine
InstitutionBeth Israel Deaconess Medical Center
DepartmentMedicine
DivisionNephrology


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Bhasin M, Huang Z, Pradhan-Nabzdyk L, Malek JY, LoGerfo PJ, Contreras M, Guthrie P, Csizmadia E, Andersen N, Kocher O, Ferran C, LoGerfo FW. Temporal network based analysis of cell specific vein graft transcriptome defines key pathways and hub genes in implantation injury. PLoS One. 2012; 7(6):e39123.
    View in: PubMed
  2. da Silva CG, Maccariello ER, Wilson SW, Putheti P, Daniel S, Damrauer SM, Peterson CR, Siracuse JJ, Kaczmarek E, Ferran C. Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-?B signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation. J Cell Physiol. 2012 Apr; 227(4):1382-90.
    View in: PubMed
  3. Siracuse JJ, Fisher MD, da Silva CG, Peterson CR, Csizmadia E, Moll HP, Damrauer SM, Studer P, Choi LY, Essayagh S, Kaczmarek E, Maccariello ER, Lee A, Daniel S, Ferran C. A20-mediated modulation of inflammatory and immune responses in aortic allografts and development of transplant arteriosclerosis. Transplantation. 2012 Feb 27; 93(4):373-82.
    View in: PubMed
  4. Wang H, Ferran C, Attanasio C, Calise F, Otterbein LE. Induction of protective genes leads to islet survival and function. J Transplant. 2011; 2011:141898.
    View in: PubMed
  5. Damrauer SM, Studer P, da Silva CG, Longo CR, Ramsey HE, Csizmadia E, Shrikhande GV, Scali ST, Libermann TA, Bhasin MK, Ferran C. A20 modulates lipid metabolism and energy production to promote liver regeneration. PLoS One. 2011; 6(3):e17715.
    View in: PubMed
  6. Shrikhande GV, Scali ST, da Silva CG, Damrauer SM, Csizmadia E, Putheti P, Matthey M, Arjoon R, Patel R, Siracuse JJ, Maccariello ER, Andersen ND, Monahan T, Peterson C, Essayagh S, Studer P, Guedes RP, Kocher O, Usheva A, Veves A, Kaczmarek E, Ferran C. O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice. PLoS One. 2010; 5(12):e14240.
    View in: PubMed
  7. Andersen ND, Chopra A, Monahan TS, Malek JY, Jain M, Pradhan L, Ferran C, LoGerfo FW. Endothelial cells are susceptible to rapid siRNA transfection and gene silencing ex vivo. J Vasc Surg. 2010 Dec; 52(6):1608-15.
    View in: PubMed
  8. Feng J, Damrauer SM, Lee M, Sellke FW, Ferran C, Abid MR. Endothelium-dependent coronary vasodilatation requires NADPH oxidase-derived reactive oxygen species. Arterioscler Thromb Vasc Biol. 2010 Sep; 30(9):1703-10.
    View in: PubMed
  9. Damrauer SM, Fisher MD, Wada H, Siracuse JJ, da Silva CG, Moon K, Csizmadia E, Maccariello ER, Patel VI, Studer P, Essayagh S, Aird WC, Daniel S, Ferran C. A20 inhibits post-angioplasty restenosis by blocking macrophage trafficking and decreasing adventitial neovascularization. Atherosclerosis. 2010 Aug; 211(2):404-8.
    View in: PubMed
  10. Ramsey HE, Da Silva CG, Longo CR, Csizmadia E, Studer P, Patel VI, Damrauer SM, Siracuse JJ, Daniel S, Ferran C. A20 protects mice from lethal liver ischemia/reperfusion injury by increasing peroxisome proliferator-activated receptor-alpha expression. Liver Transpl. 2009 Nov; 15(11):1613-21.
    View in: PubMed
  11. Tran TM, Temkin V, Shi B, Pagliari L, Daniel S, Ferran C, Pope RM. TNFalpha-induced macrophage death via caspase-dependent and independent pathways. Apoptosis. 2009 Mar; 14(3):320-32.
    View in: PubMed
  12. da Silva CG, Specht A, Wegiel B, Ferran C, Kaczmarek E. Mechanism of purinergic activation of endothelial nitric oxide synthase in endothelial cells. Circulation. 2009 Feb 17; 119(6):871-9.
    View in: PubMed
  13. Monahan TS, Andersen ND, Martin MC, Malek JY, Shrikhande GV, Pradhan L, Ferran C, LoGerfo FW. MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein. FASEB J. 2009 Feb; 23(2):557-64.
    View in: PubMed
  14. Monahan TS, Andersen ND, Panossian H, Kalish JA, Daniel S, Shrikhande GV, Ferran C, Logerfo FW. A novel function for cadherin 11/osteoblast-cadherin in vascular smooth muscle cells: modulation of cell migration and proliferation. J Vasc Surg. 2007 Mar; 45(3):581-9.
    View in: PubMed
  15. Andersen ND, Monahan TS, Malek JY, Jain M, Daniel S, Caron LD, Pradhan L, Ferran C, Logerfo FW. Comparison of gene silencing in human vascular cells using small interfering RNAs. J Am Coll Surg. 2007 Mar; 204(3):399-408.
    View in: PubMed
  16. Daniel S, Patel VI, Shrikhande GV, Scali ST, Ramsey HE, Csizmadia E, Benhaga N, Fisher MD, Arvelo MB, Ferran C. The universal NF-kappaB inhibitor a20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells. Transplant Proc. 2006 Dec; 38(10):3225-7.
    View in: PubMed
  17. Ferran C. Protective genes in the vessel wall: Modulators of graft survival and function. Transplantation. 2006 Jul 15; 82(1 Suppl):S36-40.
    View in: PubMed
  18. Patel VI, Daniel S, Longo CR, Shrikhande GV, Scali ST, Czismadia E, Groft CM, Shukri T, Motley-Dore C, Ramsey HE, Fisher MD, Grey ST, Arvelo MB, Ferran C. A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia. FASEB J. 2006 Jul; 20(9):1418-30.
    View in: PubMed
  19. Shrikhande G, Khaodhiar L, Scali S, Lima C, Hubbard M, Dudley K, Ganda O, Ferran C, Veves A. Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. J Vasc Surg. 2006 Apr; 43(4):760-70; discussion 770-1.
    View in: PubMed
  20. Kunter U, Daniel S, Arvelo MB, Choi J, Shukri T, Patel VI, Longo CR, Scali ST, Shrikhande G, Rocha E, Czismadia E, Mottley C, Grey ST, Floege J, Ferran C. Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells. Kidney Int. 2005 Oct; 68(4):1520-32.
    View in: PubMed
  21. Longo CR, Patel VI, Shrikhande GV, Scali ST, Csizmadia E, Daniel S, Sun DW, Grey ST, Arvelo MB, Ferran C. A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism. Hepatology. 2005 Jul; 42(1):156-64.
    View in: PubMed
  22. Abid MR, Yano K, Guo S, Patel VI, Shrikhande G, Spokes KC, Ferran C, Aird WC. Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. J Biol Chem. 2005 Aug 19; 280(33):29864-73.
    View in: PubMed
  23. Avihingsanon Y, Ma N, Pavlakis M, Chon WJ, Uknis ME, Monaco AP, Ferran C, Stillman I, Schachter AD, Mottley C, Zheng XX, Strom TB. On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol. 2005 Jun; 16(6):1542-8.
    View in: PubMed
  24. Storz P, Döppler H, Ferran C, Grey ST, Toker A. Functional dichotomy of A20 in apoptotic and necrotic cell death. Biochem J. 2005 Apr 1; 387(Pt 1):47-55.
    View in: PubMed
  25. Song R, Zhou Z, Kim PK, Shapiro RA, Liu F, Ferran C, Choi AM, Otterbein LE. Carbon monoxide promotes Fas/CD95-induced apoptosis in Jurkat cells. J Biol Chem. 2004 Oct 22; 279(43):44327-34.
    View in: PubMed
  26. Daniel S, Arvelo MB, Patel VI, Longo CR, Shrikhande G, Shukri T, Mahiou J, Sun DW, Mottley C, Grey ST, Ferran C. A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation. Blood. 2004 Oct 15; 104(8):2376-84.
    View in: PubMed
  27. Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H, Ferran C, Sayegh MH. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice. Transplantation. 2004 Apr 15; 77(7):990-7.
    View in: PubMed
  28. Longo CR, Arvelo MB, Patel VI, Daniel S, Mahiou J, Grey ST, Ferran C. A20 protects from CD40-CD40 ligand-mediated endothelial cell activation and apoptosis. Circulation. 2003 Sep 2; 108(9):1113-8.
    View in: PubMed
  29. Grey ST, Longo C, Shukri T, Patel VI, Csizmadia E, Daniel S, Arvelo MB, Tchipashvili V, Ferran C. Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function. J Immunol. 2003 Jun 15; 170(12):6250-6.
    View in: PubMed
  30. Kunter U, Floege J, von Jürgensonn AS, Stojanovic T, Merkel S, Gröne HJ, Ferran C. Expression of A20 in the vessel wall of rat-kidney allografts correlates with protection from transplant arteriosclerosis. Transplantation. 2003 Jan 15; 75(1):3-9.
    View in: PubMed
  31. Ferran C. The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts. Transpl Immunol. 2002 May; 9(2-4):135-6.
    View in: PubMed
  32. Avihingsanon Y, Ma N, Csizmadia E, Wang C, Pavlakis M, Giraldo M, Strom TB, Soares MP, Ferran C. Expression of protective genes in human renal allografts: a regulatory response to injury associated with graft rejection. Transplantation. 2002 Apr 15; 73(7):1079-85.
    View in: PubMed
  33. Arvelo MB, Cooper JT, Longo C, Daniel S, Grey ST, Mahiou J, Czismadia E, Abu-Jawdeh G, Ferran C. A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology. 2002 Mar; 35(3):535-43.
    View in: PubMed
  34. Millan MT, Natkunam Y, Clarke-Katzenberg R, Desai D, Prapong W, So SK, Esquivel CO, Sibley R, Ferran C, Martinez OM. Epstein-Barr virus infection is associated with endothelial Bcl-2 expression in transplant liver allografts. Transplantation. 2002 Feb 15; 73(3):465-9.
    View in: PubMed
  35. Laybutt DR, Kaneto H, Hasenkamp W, Grey S, Jonas JC, Sgroi DC, Groff A, Ferran C, Bonner-Weir S, Sharma A, Weir GC. Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia. Diabetes. 2002 Feb; 51(2):413-23.
    View in: PubMed
  36. Rocha E, Mahiou J, Badrichani AZ, Stroka DM, Ferran C. The BH4 domain of A1, an anti-apoptotic bcl family gene, is necessary and sufficient for its antiinflammatory function in endothelial cells. Transplant Proc. 2001 Feb-Mar; 33(1-2):314.
    View in: PubMed
  37. Badrichani AZ, Ferran C. A20 and BCL proteins exert a broad and complementary cytoprotective effect in endothelial cells via blockade of NF-kappaB and NFAT. Transplant Proc. 2001 Feb-Mar; 33(1-2):450.
    View in: PubMed
  38. Grey ST, Lock J, Bach FH, Ferran C. Adenovirus-mediated gene transfer of A20 in murine islets inhibits Fas-induced apoptosis. Transplant Proc. 2001 Feb-Mar; 33(1-2):577-8.
    View in: PubMed
  39. Daniel S, Arvelo M, Ferran C. Overexpression of A20 in endothelial cells of vascularized grafts creates a protective barrier against TNF- and FAS-mediated apoptosis. Transplant Proc. 2001 Feb-Mar; 33(1-2):225.
    View in: PubMed
  40. Grey ST, Arvelo MB, Hasenkamp W, Bach FH, Ferran C. A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J Exp Med. 1999 Oct 18; 190(8):1135-46.
    View in: PubMed
  41. Stroka DM, Badrichani AZ, Bach FH, Ferran C. Overexpression of A1, an NF-kappaB-inducible anti-apoptotic bcl gene, inhibits endothelial cell activation. Blood. 1999 Jun 1; 93(11):3803-10.
    View in: PubMed
  42. Bach FH, Soares M, Lin Y, Ferran C. Barriers to xenotransplantation. Transplant Proc. 1999 Jun; 31(4):1819-20.
    View in: PubMed
  43. Badrichani AZ, Stroka DM, Bilbao G, Curiel DT, Bach FH, Ferran C. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. J Clin Invest. 1999 Feb; 103(4):543-53.
    View in: PubMed
  44. Arvelo MB, Badrichani AZ, Stroka DM, Grey ST, Bach FH, Ferran C. A novel function for A20 in smooth muscle cells: inhibition of activation and proliferation. Transplant Proc. 1999 Feb-Mar; 31(1-2):858-9.
    View in: PubMed
  45. Grey ST, Arvelo MB, Hasenkamp WM, Bach FH, Ferran C. Adenovirus-mediated gene transfer of the anti-apoptotic protein A20 in rodent islets inhibits IL-1 beta-induced NO release. Transplant Proc. 1999 Feb-Mar; 31(1-2):789.
    View in: PubMed
  46. von Albertini M, Ferran C, Brostjan C, Bach FH, Goodman DJ. Membrane-associated lymphotoxin on natural killer cells activates endothelial cells via an NF-kappaB-dependent pathway. Transplantation. 1998 Nov 15; 66(9):1211-9.
    View in: PubMed
  47. Soares MP, Muniappan A, Kaczmarek E, Koziak K, Wrighton CJ, Steinhäuslin F, Ferran C, Winkler H, Bach FH, Anrather J. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis. J Immunol. 1998 Nov 1; 161(9):4572-82.
    View in: PubMed
  48. Ferran C, Stroka DM, Badrichani AZ, Cooper JT, Wrighton CJ, Soares M, Grey ST, Bach FH. A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood. 1998 Apr 1; 91(7):2249-58.
    View in: PubMed
  49. Blanco R, Gonzalez-Gay MA, Ibañez D, Lopez-Viana A, Ferran C, Regueira A, Gonzalez-Vela C. Henoch-Schönlein purpura as clinical presentation of a myelodysplastic syndrome. Clin Rheumatol. 1997 Nov; 16(6):626-8.
    View in: PubMed
  50. Bach FH, Hancock WW, Ferran C. Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol Today. 1997 Oct; 18(10):483-6.
    View in: PubMed
  51. Bach FH, Ferran C, Soares M, Wrighton CJ, Anrather J, Winkler H, Robson SC, Hancock WW. Modification of vascular responses in xenotransplantation: inflammation and apoptosis. Nat Med. 1997 Sep; 3(9):944-8.
    View in: PubMed
  52. Millan MT, Geczy C, Stuhlmeier KM, Goodman DJ, Ferran C, Bach FH. Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression. Transplantation. 1997 Feb 15; 63(3):421-9.
    View in: PubMed
  53. Stroka DM, Cooper JT, Brostjan C, Millan MT, Goodman DJ, Wrighton CJ, Bach FH, Ferran C. Expression of a negative dominant mutant of human p55 tumor necrosis factor-receptor inhibits TNF and monocyte-induced activation in porcine aortic endothelial cells. Transplant Proc. 1997 Feb-Mar; 29(1-2):882.
    View in: PubMed
  54. Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, Ferran C. A20 expression inhibits endothelial cell activation. Transplant Proc. 1997 Feb-Mar; 29(1-2):881.
    View in: PubMed
  55. Bach FH, Ferran C, Candinas D, Miyatake T, Koyamada N, Mark W, Hechenleitner P, Hancock WW. Accommodation of xenografts: expression of "protective genes" in endothelial and smooth muscle cells. Transplant Proc. 1997 Feb-Mar; 29(1-2):56-8.
    View in: PubMed
  56. Bach FH, Ferran C, Hechenleitner P, Mark W, Koyamada N, Miyatake T, Winkler H, Badrichani A, Candinas D, Hancock WW. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med. 1997 Feb; 3(2):196-204.
    View in: PubMed
  57. Ferran C, Stroka DM, Badrichani AZ, Cooper JT, Bach FH. Adenovirus-mediated gene transfer of A20 renders endothelial cells resistant to activation: a means of evaluating the role of endothelial cell activation in xenograft rejection. Transplant Proc. 1997 Feb-Mar; 29(1-2):879-80.
    View in: PubMed
  58. Ferran C, Badrichani AZ, Cooper JT, Stroka DM, Bach FH. Xenotransplantation: progress toward clinical development. Adv Nephrol Necker Hosp. 1997; 27:391-420.
    View in: PubMed
  59. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC. Delayed xenograft rejection. Immunol Today. 1996 Aug; 17(8):379-84.
    View in: PubMed
  60. Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, Ferran C. A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism. J Biol Chem. 1996 Jul 26; 271(30):18068-73.
    View in: PubMed
  61. Ferran C, Cooper JT, Brostjan C, Stroka DM, Millan MT, Goodman DJ, Bach FH. Expression of a truncated form of the human p55 TNF-receptor in bovine aortic endothelial cells renders them resistant to human TNF. Transplant Proc. 1996 Apr; 28(2):618-9.
    View in: PubMed
  62. Bach FH, Winkler H, Wrighton CJ, Robson SC, Stuhlmeier K, Ferran C. Xenotransplantation: a possible solution to the shortage of donor organs. Transplant Proc. 1996 Feb; 28(1):416-7.
    View in: PubMed
  63. Bach FH, Robson SC, Wrighton CJ, Stuhlmeier K, Ferran C, Winkler H. Genetic engineering of endothelial cells to ameliorate xenograft rejection. Clin Transplant. 1996 Feb; 10(1 Pt 2):124-7.
    View in: PubMed
  64. Goumy L, Ferran C, Merite S, Bach JF, Chatenoud L. In vivo anti-CD3-driven cell activation. Cellular source of induced tumor necrosis factor, interleukin-1 beta, and interleukin-6. Transplantation. 1996 Jan 15; 61(1):83-7.
    View in: PubMed
  65. Ferran C, Millan MT, Csizmadia V, Cooper JT, Brostjan C, Bach FH, Winkler H. Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation. Biochem Biophys Res Commun. 1995 Sep 5; 214(1):212-23.
    View in: PubMed
  66. Bach FH, Robson SC, Winkler H, Ferran C, Stuhlmeier KM, Wrighton CJ, Hancock WW. Barriers to xenotransplantation. Nat Med. 1995 Sep; 1(9):869-73.
    View in: PubMed
  67. Bach FH, Robson SC, Ferran C, Millan M, Anrather J, Kopp C, Lesnikoski B, Goodman DJ, Hancock WW, Wrighton C, et al. Xenotransplantation: endothelial cell activation and beyond. Transplant Proc. 1995 Feb; 27(1):77-9.
    View in: PubMed
  68. Millan MT, Ferran C, Winkler H, Blakely ML, van der Werf WJ, Hancock WW, Bach FH. Xenotransplantation: problems and approaches. Transplant Proc. 1994 Dec; 26(6):3593-6.
    View in: PubMed
  69. Bach FH, Robson SC, Ferran C, Winkler H, Millan MT, Stuhlmeier KM, Vanhove B, Blakely ML, van der Werf WJ, Hofer E, et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev. 1994 Oct; 141:5-30.
    View in: PubMed
  70. Ferran C, Dautry F, Mérite S, Sheehan K, Schreiber R, Grau G, Bach JF, Chatenoud L. Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. J Clin Invest. 1994 May; 93(5):2189-96.
    View in: PubMed
  71. Ferran C, Bach JF, Chatenoud L. [Monoclonal antibodies. Diagnostic and therapeutic use and prospects for the future]. Rev Fr Transfus Hemobiol. 1993 Apr; 36(2):149-77.
    View in: PubMed
  72. Ferran C, Bach JF, Chatenoud L. In vivo T cell activation properties of anti-T cell monoclonal antibodies. Exp Nephrol. 1993 Mar-Apr; 1(2):83-9.
    View in: PubMed
  73. Ferran C, Peuchmaur M, Desruennes M, Ghoussoub JJ, Cabrol A, Brousse N, Cabrol C, Bach JF, Chatenoud L. Implications of de novo ELAM-1 and VCAM-1 expression in human cardiac allograft rejection. Transplantation. 1993 Mar; 55(3):605-9.
    View in: PubMed
  74. Ferran C. [T lymphocyte activation induced in vivo in different strains of mice after injection of anti-CD3 antibodies: prevention by an anti- TNF antibody]. Nephrologie. 1993; 14(1):23-4.
    View in: PubMed
  75. Charpentier B, Hiesse C, Lantz O, Ferran C, Stephens S, O'Shaugnessy D, Bodmer M, Benoit G, Bach JF, Chatenoud L. Evidence that antihuman tumor necrosis factor monoclonal antibody prevents OKT3-induced acute syndrome. Transplantation. 1992 Dec; 54(6):997-1002.
    View in: PubMed
  76. Ferran C, Dy M, Sheehan K, Merite S, Schreiber R, Landais P, Grau G, Bluestone J, Bach JF, Chatenoud L. Inter-mouse strain differences in the in vivo anti-CD3 induced cytokine release. Clin Exp Immunol. 1991 Dec; 86(3):537-43.
    View in: PubMed
  77. Charpentier B, Hiesse C, Ferran C, Lantz O, Fries D, Bach JF, Chatenoud L. [Acute clinical syndrome associated with OKT3 administration. Prevention by single injection of an anti-human TNF monoclonal antibody]. Presse Med. 1991 Nov 27; 20(40):2009-11.
    View in: PubMed
  78. Ferran C, Dy M, Sheehan K, Schreiber R, Grau G, Bluestone J, Bach JF, Chatenoud L. Cascade modulation by anti-tumor necrosis factor monoclonal antibody of interferon-gamma, interleukin 3 and interleukin 6 release after triggering of the CD3/T cell receptor activation pathway. Eur J Immunol. 1991 Oct; 21(10):2349-53.
    View in: PubMed
  79. Ferran C, Sheehan K, Schreiber R, Bach JF, Chatenoud L. Anti-TNF abrogates the cytokine-related anti-CD3 induced syndrome. Transplant Proc. 1991 Feb; 23(1 Pt 1):849-50.
    View in: PubMed
  80. Chatenoud L, Legendre C, Ferran C, Bach JF, Kreis H. Corticosteroid inhibition of the OKT3-induced cytokine-related syndrome--dosage and kinetics prerequisites. Transplantation. 1991 Feb; 51(2):334-8.
    View in: PubMed
  81. Chatenoud L, Ferran C, Bach JF. Clinical applications of anti-T-cell monoclonal antibodies. Adv Nephrol Necker Hosp. 1991; 20:281-304.
    View in: PubMed
  82. Chatenoud L, Ferran C, Bach JF. The anti-CD3-induced syndrome: a consequence of massive in vivo cell activation. Curr Top Microbiol Immunol. 1991; 174:121-34.
    View in: PubMed
  83. Hardesty C, Ferran C, DiRienzo JM. Plasmid-mediated sucrose metabolism in Escherichia coli: characterization of scrY, the structural gene for a phosphoenolpyruvate-dependent sucrose phosphotransferase system outer membrane porin. J Bacteriol. 1991 Jan; 173(2):449-56.
    View in: PubMed
  84. Chatenoud L, Ferran C, Bach JF. In vivo use of OKT3: main issues for the monitoring of treated patients. Transplant Proc. 1990 Dec; 22(6):2605-8.
    View in: PubMed
  85. Ferran C, Dy M, Merite S, Sheehan K, Schreiber R, Leboulenger F, Landais P, Bluestone J, Bach JF, Chatenoud L. Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids. Transplantation. 1990 Oct; 50(4):642-8.
    View in: PubMed
  86. Chatenoud L, Ferran C, Legendre C, Kurrle R, Kreis H, Bach JF. Immunological follow-up of renal allograft recipients treated with the BMA 031 (anti-TCR) monoclonal antibody. Transplant Proc. 1990 Aug; 22(4):1787-8.
    View in: PubMed
  87. Ferran C, Bluestone J, Bach JF, Chatenoud L. In vivo T lymphocyte activation induced in mice following the injection of anti-CD3 monoclonal antibody. Transplant Proc. 1990 Aug; 22(4):1922-3.
    View in: PubMed
  88. Chatenoud L, Ferran C, Legendre C, Thouard I, Merite S, Reuter A, Gevaert Y, Kreis H, Franchimont P, Bach JF. In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids. Transplantation. 1990 Apr; 49(4):697-702.
    View in: PubMed
  89. Ferran C, Sheehan K, Dy M, Schreiber R, Merite S, Landais P, Noel LH, Grau G, Bluestone J, Bach JF, et al. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur J Immunol. 1990 Mar; 20(3):509-15.
    View in: PubMed
  90. Chatenoud L, Ferran C, Bach JF. In-vivo anti-CD3 treatment of autoimmune patients. Lancet. 1989 Jul 15; 2(8655):164.
    View in: PubMed
  91. Chatenoud L, Ferran C, Reuter A, Legendre C, Gevaert Y, Kreis H, Franchimont P, Bach JF. Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]. N Engl J Med. 1989 May 25; 320(21):1420-1.
    View in: PubMed
  92. Pochet JM, Albouze G, Bobrie G, Landais P, Ferran C, Grünfeld JP. The natural history of inherited renal diseases. Contrib Nephrol. 1989; 75:100-7.
    View in: PubMed
  93. Chatenoud L, Ferran C, Reuter A, Legendre C, Gevaert Y, Kreis H, Franchimont P, Bach JF. [T lymphocyte activation induced in vivo by the first injection of OKT3 monoclonal antibodies]. C R Acad Sci III. 1988; 307(19):833-6.
    View in: PubMed
  94. Hardesty C, Colón G, Ferran C, DiRienzo JM. Deletion analysis of sucrose metabolic genes from a Salmonella plasmid cloned in Escherichia coli K12. Plasmid. 1987 Sep; 18(2):142-55.
    View in: PubMed
  95. Laborit H, Baron C, Ferran C, Henriet I. Action of certain pharmacological associations on the level of cerebral biogenic amines and some metabolites in the curative treatment of hemorrhagic shock in rats. Res Commun Chem Pathol Pharmacol. 1984 Mar; 43(3):435-47.
    View in: PubMed
  96. Laborit H, Baron C, Ferran C, Henriet I. Assay of cerebral catecholamines, serotonin and their metabolites in experimental hemorrhagic shock in rats. Res Commun Chem Pathol Pharmacol. 1984 Mar; 43(3):425-33.
    View in: PubMed
  97. Bonifacj JF, Ferran C, Laborit H. [Effect of piracetam on metabolic stages in the rat brain]. Agressologie. 1982 Oct; 23(4):127-9.
    View in: PubMed
  98. Laborit H, Baron C, Ferran C, Henriet I. [Effect of minaprine on arterial pressure and levels of cerebral amines in spontaneously hypertensive rats]. Agressologie. 1982 Mar; 23(1):15-8.
    View in: PubMed
  99. Ferran C. [Life-expectancy in the acute leukaemias (author's transl)]. Sangre (Barc). 1981; 26(5-C):1028-32.
    View in: PubMed
  100. Laborit H, Baron C, Ferran C, Henriet I. [Variations in blood lactic acid and glucose levels in the rabbit after infusion of isoprenaline with or without prior infusion of minaprine]. Agressologie. 1981; 22(2):63-4.
    View in: PubMed
  101. Laborit H, Baron C, Ferran C, Henriet I. [Effects of minaprine hydrochloride on changes in body weight, blood pressure and cerebral amine concentrations induced by unavoidable planter electric shock]. Agressologie. 1981; 22(2):59-62.
    View in: PubMed
  102. Laborit H, Baron C, Ferran C, Bonifacj JF, Topall G, Henriet I. [Variations in the toxicity of cadmium in relation to the possibility of controlling the environmental status by motor activity in the rat]. Agressologie. 1980; 21(6):269-90.
    View in: PubMed
  103. Laborit H, Baron C, Ferran C, Laborit G. [Biochemical and neurophysiological study of various fish toxins]. Agressologie. 1979; 20(2):81-96.
    View in: PubMed
  104. Vivancos Pujol MP, Alemany A, Clavo M, Rubio Baget A, Sans Botargues R, Ferran C. [Granulocyte transfusion. Its efficacy as a complementary treatment of infections in the granulocytopenic patient (author's transl)]. Sangre (Barc). 1979; 24(5B):896-903.
    View in: PubMed
  105. Laborit H, Ferran C. [Decrease in erythrocyte 2,3 diphosphoglycerate levels in relation to elevated lactate concentration in the medium and restoration of these levels under the influence of dihydroxyacetone]. Agressologie. 1976; 17(5):265-71.
    View in: PubMed
  106. Rozman C, Triginer J, Ribas-Mundo M, Ferran C, Visa J, Gonzales E. The value of laparotomy and splenectomy in the staging of 56 patients with Hodgkin's disease. Acta Haematol. 1973; 50(6):321-8.
    View in: PubMed
  107. Ferran C, González E, Arangüena PV, Irriguible MD, Acebedo G, Rubio D, García J, Triginer J, Lara F. [Laparotomy in Hodgkin's disease]. Sangre (Barc). 1972; 17(3):301-8.
    View in: PubMed
  108. Muxi M, Perez Soler J, Mateu JM, Morales V, Ferran C, Alonso C, Jordan C, Gonzales E, Salvador Monte R. [Intrauterine transfusion]. Minerva Ginecol. 1970 Jul 13; 22(14):701-3.
    View in: PubMed
  109. Muxi M, Perez Soler J, Mateu JM, Morales V, Ferran C, Alonso C, Jordan C, Gonzales E. [Study of the amniotic fluid]. Minerva Ginecol. 1970 Jul 13; 22(14):716-8.
    View in: PubMed
  110. Ferran C. [Psychotropic drugs and placebos in a medico-pedagogical institute. Introduction to a study of the psycho-affective reactions produced within the care team by prescription]. Rev Neuropsychiatr Infant. 1969 Dec; 17(12):827-33.
    View in: PubMed
  111. DARMAILLACQ R, FERRAN C, GAUTIER G. [Torsions of the great omentum. Apropos of 3 cases]. Bord Chir. 1961 Apr; 2:73-8.
    View in: PubMed
  112. FERRAN C. [Not Available]. Toulouse Med. 1948 May; 49(5):365-70.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Ferran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (493) concept(s)
_
Co-Authors
See all (40) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_